Mesothelioma Hub is a trusted resource dedicated to supporting those affected by mesothelioma. Our team of medical and legal experts bring insightful, reliable, and recent information on mesothelioma healthcare, from survivor stories and medical breakthroughs to guidance on treatment options and connecting with specialists.
An experimental drug that uses mesothelioma’s response to cellular stress against it showed early signs of activity in a small phase 1 clinical trial. The drug, called RSO-021, is designed to block an enzyme that helps mesothelioma cells survive. Researchers reported that six of nine evaluable patients with previously [...]
Researchers will present the first clinical findings for ISM6331, an experimental drug being studied in patients with advanced mesothelioma and other solid tumors, at the European Society for Medical Oncology Congress in October 2026. ISM6331 is an oral targeted therapy designed to interfere with proteins that may help mesothelioma [...]
A phase 2 clinical trial is studying whether adding the immunotherapy drug Keytruda to chemotherapy before surgery can improve outcomes for certain patients with pleural mesothelioma. The CHIMERA trial is evaluating Keytruda, also known as pembrolizumab, with platinum-based chemotherapy and pemetrexed before mesothelioma surgery. Participants who undergo surgery then [...]
Cryoablation is a minimally invasive treatment that uses very cold temperatures to freeze and destroy cancer cells. For people with mesothelioma, it is being explored as a possible option, especially if you are looking into newer or less invasive approaches. While cryoablation is not currently a standard treatment for [...]
Researchers are exploring whether a new MRI-based mesothelioma test could help detect tumors earlier than current diagnostic methods. A recent radiology study found that subtle patterns in how tissue absorbs contrast during MRI scans may signal early mesothelioma, which could eventually help doctors diagnose the disease sooner. Researchers are [...]
Researchers are currently studying a new promising drug for people with mesothelioma in hopes of moving closer to eliminating tumors. This mesothelioma oral medication is being included in a phase 1, multi-center, open-label study to evaluate the safety, tolerability, and PK of VT3989 in patients with refractory locally advanced [...]
In a recent study conducted by a team of scientists in Italy, the antitumoral effects of Bortezomib Velcade were explored, igniting excitement within the medical community and among patients and their families. The findings, published in April 2023, promised results that have the potential to reshape the landscape of [...]
New research shows that genetic inheritance of the BAP1 protein mutation could lead to an eventual diagnosis of mesothelioma, the deadly cancer caused by prolonged asbestos exposure. This research started a spiral of new research looking into the two types of BAP1 genes, an inherited germline BAP1 mutation from [...]
The International Mesothelioma Program is a center for mesothelioma research and treatment at the Brigham and Women’s Hospital in Boston, Massachusetts. Since 2002, the team of more than 80 caregivers, scientists, and support staff have worked to develop new treatment strategies and improve the quality of life for mesothelioma [...]
